Ballicules.com

Dextroamphetamine spansule

DEXEDRINE SPANSULE

What it isExtended-release dopamine-releasing amphetamine stimulant; ADHD.

Why this oneWith 50% IR / 50% sustained-release beads, it extends the active d-enantiomer; Duration of action 6-8 h (Carlat Table 1).

What limits itAppetite loss, insomnia, and blood-pressure elevation can limit use. Schedule II; misuse and dependence remain concerns.

FDA-approved for

FDA label

BOXED WARNING High potential for abuse, misuse, and addiction; misuse/abuse of CNS stimulants can cause overdose and death.
FDA dosingPopulationStartTargetMax
NarcolepsyAdults and children (6-11 yr start 5 mg QD; ≥12 yr start 10 mg QD)10 mg/day (≥12 yr); 5 mg/day (6-11 yr)raise weekly (5 mg for 6-11 yr; 10 mg for ≥12 yr) to optimal responseup to 60 mg/day (usual 5-60 mg/day divided)
ADHDPediatric 6-16 yr5 mg once or twice dailyraise weekly by 5 mg to optimal responserarely exceed 40 mg/day

Titration Raise dose in 5 mg (ADHD; narcolepsy 6-11 yr) or 10 mg (narcolepsy ≥12 yr) increments at weekly intervals

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Embryotoxic/teratogenic in mice at high multiples of human dose; use only if potential benefit justifies risk; infants of dependent mothers at risk of prematurity, low birth weight, withdrawal

Lactation Amphetamines are excreted in human milk; mothers should refrain from nursing

⚠ BOXED WARNING

Classes and tags

Clinical profile

Direct muscarinic antagonism0 / 4

Mechanism of action: Dextroamphetamine spansule ballicule

Dextroamphetamine spansule ballicule: receptor binding, kinetics and half-life diagram

Open Dextroamphetamine spansule in the interactive console ↗

Memory aids: mascots and interaction avatars

Dextroamphetamine spansule DEXEDRINE mascot mnemonic cartoon
“Dexter amphetamine”

Open Dextroamphetamine spansule in the interactive console ↗